Recent Advances in Oral Delivery of Biologics
Keywords:
Absorption enhancement, Biologics, Microneedle capsule, Nanomedicine, Oral delivery of biologics, UltrasoundAbstract
For the majority of patients, taking medications orally is the most beneficial method. The majority of doctors choose it because it is the most straightforward, practical, patient-complies, and non-invasive approach. Given the different gastrointestinal barriers, metabolic diseases, inflammatory illnesses, and ageing, oral biologic administration is not as helpful as other routes because to the harsh environment of the gastrointestinal tract. Various pharmaceutical technologies, such as cyclodextrins, micelles, nano carriers, and lipid-based carriers, have been investigated as drug delivery systems to improve oral medication absorption. Because it is usually the simplest and most comfortable method, patients tend to choose oral medicine administration. Because of all of its advantages—which include non-invasiveness, patient compliance, and ease of drug administration—it is usually the best option for doctors. Therapeutic efficacy and the short- and long-term biological consequences are significantly influenced by the routes of drug administration and the corresponding physicochemical properties of a given route. In the meanwhile, there are certain difficulties with oral delivery, which have dominated the field's recent research efforts. The most popular method for delivering drugs locally and systemically is oral administration.mechanisms, ideas, and elements.
Downloads
References
Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2003;20(2&3). https://pubmed.ncbi.nlm.nih.gov/14584523/
Eek D, Krohe M, Mazar I, Horsfield A, Pompilus F, Friebe R, Shields AL. Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature. Patient preference and adherence. 2016 Aug 24:1609-21. https://pubmed.ncbi.nlm.nih.gov/27601886/
Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert opinion on drug delivery. 2015 Sep 2;12(9):1459-73. https://pubmed.ncbi.nlm.nih.gov/25813361/
Gedawy A, Martinez J, Al-Salami H, Dass CR. Oral insulin delivery: existing barriers and current counter-strategies. Journal of pharmacy and pharmacology. 2018 Feb;70(2):197-213. https://pubmed.ncbi.nlm.nih.gov/29193053/
Vidal-Alaball J, Butler CC, Potter CC. Comparing costs of intramuscular and oral vitamin B12 administration in primary care: a cost-minimization analysis. The European journal of general practice. 2006 Jan 1;12(4):169-73.
https://pubmed.ncbi.nlm.nih.gov/17127603/
Anderberg EK, Nyström C, Artursson P. Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco‐2) cells. Journal of pharmaceutical sciences. 1992 Sep 1;81(9):879-87.
Fix JA, Engle KA, Porter PA, Leppert PS, Selk SJ, Gardner CR, Alexander J. Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. American Journal of Physiology-Gastrointestinal and Liver Physiology. 1986 Sep 1;251(3):G332-40.
Vllasaliu D, Casettari L, Fowler R, Exposito-Harris R, Garnett M, Illum L, Stolnik S. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study. International journal of pharmaceutics. 2012 Jul 1;430(1-2):151-60.
Vllasaliu D, Exposito-Harris R, Heras A, Casettari L, Garnett M, Illum L, Stolnik S. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution. International journal of pharmaceutics. 2010 Nov 15;400(1-2):183-93.
Krauland AH, Guggi D, Bernkop-Schnürch A. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. Journal of Controlled Release. 2004 Mar 24;95(3):547-55.
Gupta V, Hwang BH, Lee J, Anselmo AC, Doshi N, Mitragotri S. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. Journal of controlled release. 2013 Dec 28;172(3):753-62.
Aungst BJ. Absorption enhancers: applications and advances. The AAPS journal. 2012 Mar;14(1):10-8.
Florence AT. The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. Pharmaceutical research. 1997 Mar;14:259-66.
Lundquist P, Artursson P. Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues. Advanced drug delivery reviews. 2016 Nov 15;106:256-76.
Dey B, Katakam P, Mitra A, Chandu BR. Comparative evaluation of hypoglycemic potentials of eucalyptus spp. leaf extracts and their encapsulations for controlled delivery. J Pharm Drug Deliv Res. 2014;3(2).
Mao M, Alavi MV, Labelle-Dumais C, Gould DB. Type IV collagens and basement membrane diseases: cell biology and pathogenic mechanisms. Current topics in membranes. 2015 Jan 1;76:61-116.
Buchiraju R, Nama S, Sakala B, Chandu BR, Kommu A, Chebrolu JK, Narasimhamurthy Y. Vesicular drug delivery system-an over view. Res J Pharm Biol Chem Sci. 2013 Jul;4(3):462-74.
Alfano MC, Chasens AI, Masi CW. Autoradiographic study of the penetration of radiolabelled dextrans and inulin through non‐keratinized oral mucosain vitro. Journal of Periodontal Research. 1977 Oct;12(5):368-77.
Banerjee A, Mitragotri S. Intestinal patch systems for oral drug delivery. Current Opinion in Pharmacology. 2017 Oct 1;36:58-65.
Sosnik A, Augustine R. Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them. Advanced drug delivery reviews. 2016 Aug 1;103:105-20.
Published
How to Cite
Issue
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.